Effect of latanoprost on regional blood flow and capillary permeability inthe monkey eye

Citation
J. Stjernschantz et al., Effect of latanoprost on regional blood flow and capillary permeability inthe monkey eye, ARCH OPHTH, 117(10), 1999, pp. 1363-1367
Citations number
28
Categorie Soggetti
Optalmology,"da verificare
Journal title
ARCHIVES OF OPHTHALMOLOGY
ISSN journal
00039950 → ACNP
Volume
117
Issue
10
Year of publication
1999
Pages
1363 - 1367
Database
ISI
SICI code
0003-9950(199910)117:10<1363:EOLORB>2.0.ZU;2-P
Abstract
Objective: To evaluate the effects of latanoprost on regional blood flow an d capillary permeability in the monkey eye. Methods: Anesthetized cynomolgus monkeys were unilaterally treated with a s ingle dose containing 6 mu g of latanoprost; or 10 mu g of PhXA34 (13,14-di hydro-15R, S-17-phcnyl-18,19,20-trinor-prostaglandin F-2 alpha [PGF(2 alpha )]-isopropyl ester), which contains about 50% latanoprost. Regional blood f low in the eye was measured with radioactively labeled microspheres; capill ary permeability was measured by determining the extravascular plasma-equiv alent albumin space using I-125-albumin, I-131-albumin, and Cr-51-labeled e rythrocytes. Results: Latanoprost or PhXA34 had no or only a slight effect on the region al blood flow when measured 1, 2 1/2, 3, 4 1/2,and 6 hours after dose admin istration, with the exception of the anterior sclera, in which a moderate i ncrease in blood flow was detected. No effect on capillary permeability to albumin was detected when studied 30 minutes to 2 1/2 hours and 5 to 6 hour s after dose administration. Conclusion: Latanoprost, a selective prostaglandin F receptor agonist, exer ted no or only;light vascular effects for up to 6 hours after dose administ ration in the monkey eye, with the exception of the anterior sclera, in whi ch a moderate increase in blood flow was detected. Clinical Relevance: Naturally occurring prostaglandins may cause marked mic rocirculatory changes in the eye that could be of clinical concern. Latanop rost, a selective prostaglandin F receptor agonist, seems to be devoid of s uch effects.